Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(12):893-895; doi:10.1093/jnci/93.12.893
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Reynolds, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 12, 893-895, June 20, 2001
© 2001 Oxford University Press

NEWS

IARC Shifts Priorities as Research Needs Change

Tom Reynolds

When Paul Kleihues, M.D., became director of the International Agency for Research on Cancer in 1994, he set out to make IARC more flexible and responsive to a fast-moving scientific agenda.


Figure Removed (Available Only in the Full Text)
View larger version (143K):
[in this window]
[in a new window]
  		Dr. Paul Kleihues

 
Beefing up the scientific staff by 25% and cutting the administration, he also reshuffled the agency’s organizational charts, creating many smaller units to allow young investigators to head their own research groups. And, in a break from the past, IARC units would not necessarily exist forever, but would be re-evaluated after 5 years. At the end of this trial period, if the unit was to be made permanent, the group leader would have to compete for the job with outside candidates. IARC’s mission . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?